Trial intelligence / Profile preview

OPTIMIST-h: Opioid titration using nociception monitors in laparoscopic hysterectomy

jRCTs052230195Completed

Sponsor
Nara Medical University
Start
Mar 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised trial of remifentanil in hysterectomy (3 arms), sponsored by Nara Medical University. Primary endpoint: Intraoperative remifentanil usage normalized by time and ideal body weight. Started Mar 2024; status: completed.

02

Drugs

remifentanil
03

Conditions

hysterectomy

Beyond the preview

Go deeper on jRCTs052230195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs052230195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call